isoproterenol and n-(n-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester

isoproterenol has been researched along with n-(n-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cai, JJ; Chen, LZ; Chen, X; Gao, Z; Gong, YS; Huang, WJ; Wang, LX; Zhang, HQ; Zhou, H; Zhou, X	1

Other Studies

1 other study(ies) available for isoproterenol and n-(n-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester

Article	Year
Relaxin inhibits cardiac fibrosis and endothelial-mesenchymal transition via the Notch pathway. Drug design, development and therapy, 2015, Volume: 9 Topics: Animals; Cardiomyopathies; Cell Movement; Cells, Cultured; Collagen; Dipeptides; Disease Models, Animal; Endothelial Cells; Epithelial-Mesenchymal Transition; Fibrosis; Human Umbilical Vein Endothelial Cells; Humans; Isoproterenol; Male; Myocardium; Neovascularization, Physiologic; Rats, Sprague-Dawley; Receptor, Notch1; Relaxin; Signal Transduction; Ventricular Function, Left	2015

Article

Year

Relaxin inhibits cardiac fibrosis and endothelial-mesenchymal transition via the Notch pathway.

Drug design, development and therapy, 2015, Volume: 9

Topics: Animals; Cardiomyopathies; Cell Movement; Cells, Cultured; Collagen; Dipeptides; Disease Models, Animal; Endothelial Cells; Epithelial-Mesenchymal Transition; Fibrosis; Human Umbilical Vein Endothelial Cells; Humans; Isoproterenol; Male; Myocardium; Neovascularization, Physiologic; Rats, Sprague-Dawley; Receptor, Notch1; Relaxin; Signal Transduction; Ventricular Function, Left

2015